SACUBRIGHT 200 Mg Tablet : MedlinePlus Drug Information….

May 17, 2024

SACUBRIGHT 200 Mg 

Sacubitril (97mg) and Valsartan (103mg)

SACUBRIGHT 200 combines Sacubitril (97mg) and Valsartan (103mg) in a single tablet, offering a powerful treatment for heart failure. This innovative medication leverages the benefits of both components to enhance heart function and improve patient outcomes. In this article, we'll explore the composition, benefits, usage, and precautions of SACUBRIGHT 200.

Composition

  • Sacubitril (97mg): Sacubitril is a neprilysin inhibitor that helps to relax blood vessels, reduce sodium retention, and lower blood pressure. By inhibiting neprilysin, it prevents the breakdown of natriuretic peptides, which are beneficial for heart health.
  • Valsartan (103mg): Valsartan is an angiotensin II receptor blocker (ARB) that helps to lower blood pressure and decrease the strain on the heart. It blocks the action of angiotensin II, a substance in the body that causes blood vessels to tighten and narrow.

Benefits

  1. Improved Heart Function: SACUBRIGHT 200 enhances heart efficiency by combining the effects of Sacubitril and Valsartan, leading to better management of heart failure symptoms.
  2. Reduced Hospitalizations: Studies have shown that this combination therapy reduces the risk of hospitalization due to heart failure.
  3. Enhanced Quality of Life: Patients often experience improved exercise tolerance and a better overall quality of life.

Usage

SACUBRIGHT 200 is typically prescribed for patients with chronic heart failure to reduce the risk of cardiovascular death and hospitalization. The recommended dosage and duration of treatment should be determined by a healthcare professional based on the patient's condition and response to therapy.

Precautions

  1. Consult Your Doctor: Before starting SACUBRIGHT 200, inform your doctor about any medical conditions, allergies, or medications you are currently taking.
  2. Monitor Blood Pressure: Regular monitoring of blood pressure is essential, as SACUBRIGHT 200 can cause hypotension (low blood pressure).
  3. Kidney Function: Patients with impaired kidney function should use this medication cautiously and under medical supervision.
  4. Pregnancy and Breastfeeding: SACUBRIGHT 200 is not recommended for use during pregnancy or breastfeeding. Consult your doctor for alternative treatments.

Side Effects

Common side effects of SACUBRIGHT 200 include dizziness, fatigue, cough, and elevated blood potassium levels. Serious side effects are rare but may include kidney dysfunction and severe allergic reactions.

Conclusion

SACUBRIGHT 200 offers a promising option for managing heart failure by combining the strengths of Sacubitril and Valsartan. With proper usage and precautions, it can significantly improve heart function, reduce hospitalizations, and enhance the quality of life for patients with chronic heart failure. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW

SHARE WITH